For citations:
Bakhtiyarova KZ, Boyko AN, Vlasov YV, Goncharova ZA, Davydovskaya MV, Zakharova MN, Malkova NA, Nilov AI, Sivertseva SA, Spirin NN, Totolyan NA, Khabirov FA, Shumilina MV. Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(3):93-99. (In Russ.) https://doi.org/10.14412/2074-2711-2020-3-93-99